Legislators
Bills
Statements
Represent

S.RES.97: A resolution expressing the sense of the Senate that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs.

About this Bill

This bill was introduced in the 113th Congress
This bill is primarily about health
You can read the bill
Sponsor Tom Coburn, R-Okla.
Total Cosponsors 3 (1 Democrat, 2 Republicans)
Introduced April 15, 2013
Latest Major Action April 15, 2013
See it on GovTrack
See it on C-SPAN

Bill Progress

  • Bill introduced in the Senate   
  • Bill passed in the Senate   
  • Bill passed in the House   
  • Bill signed into law

Bill Summary

Expresses the sense of the Senate that the Food and Drug Administration (FDA) should exercise its acknowledged authority to: (1) refuse to approve generic versions of non-abuse-deterrent opioid products that have been replaced in the market with abuse-deterrent formulations recognized by FDA as effective, and (2) require generic versions of abuse-deterrent opioid products to be formulated with comparable abuse-deterrent features.

(Source: Congressional Research Service)

Bill Actions

Date Description
April 15, 2013 Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S2654)